Stephen T. Worland - May 13, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
President and Chief Executive, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
May 13, 2022
Transactions value $
$2,811
Form type
4
Date filed
5/17/2022, 08:44 PM
Previous filing
Jan 24, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2.81K +1.84K +0.95% $1.53 195K May 13, 2022 Direct F1, F2
holding EFTR Common Stock 562K May 13, 2022 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
F2 The Form 4 previously filed on behalf of the Reporting Person on August 27, 2021 inadvertently overstated the number of shares held directly following the transactions reported therein. This reflects the correct number of shares directly and indirectly held by the Reporting person following the previously reported transactions and the transaction reported herein.